These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12394396)

  • 21. Consensus interferon and ribavirin for patients with chronic hepatitis C and failure of previous interferon-alpha therapy.
    Böcher WO; Schuchmann M; Link R; Hillenbrand H; Rahman F; Sprinzl M; Mudter J; Löhr HF; Galle PR
    Liver Int; 2006 Apr; 26(3):319-25. PubMed ID: 16584394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The role and possibilities of natural interferon treatment in chronic hepatitis C: experience with natural interferon treatment for patients barred from combined antiviral therapy because of the STOP rule].
    Horváth G; Tolvaj G; Halász T; Stotz G
    Orv Hetil; 2007 Aug; 148(33):1545-50. PubMed ID: 17686672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IFN/RBV treatment induced neutropenia and its correction with neupogen in patients with hepatitis C.
    Sharvadze L; Gochitashvili N; Tophuria A; Bolokadze N; Tsertsvadze T
    Georgian Med News; 2007 Jun; (147):52-5. PubMed ID: 17660602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Side effects. Safety and effectiveness of interferon and ribavirin in HIV+ people co-infected with hepatitis C virus.
    TreatmentUpdate; 2001; 12(8):4-5. PubMed ID: 12132439
    [No Abstract]   [Full Text] [Related]  

  • 25. Combined antiviral therapy of hepatitis C virus in dialysis patients: meta-analysis of clinical trials.
    Fabrizi F; Dixit V; Martin P; Messa P
    J Viral Hepat; 2011 Jul; 18(7):e263-9. PubMed ID: 21108701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prevention of adverse effects in ribavirin and interferon combination therapy].
    Izumi N
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):523-7. PubMed ID: 15359855
    [No Abstract]   [Full Text] [Related]  

  • 27. Chronic hepatitis C infection in the elderly.
    Huang CF; Chuang WL; Yu ML
    Kaohsiung J Med Sci; 2011 Dec; 27(12):533-7. PubMed ID: 22208535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current therapies for chronic hepatitis C.
    Ferguson MC
    Pharmacotherapy; 2011 Jan; 31(1):92-111. PubMed ID: 21182362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of newly diagnosed hepatitis C virus infection.
    Russo MW; Zacks SL; Fried MW
    Cleve Clin J Med; 2003 Sep; 70 Suppl 4():S14-20. PubMed ID: 14558641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dermatological side-effects in hepatitis C infected patients under a triple regimen associating pegylated interferon, ribavirin and telaprevir.
    Bernardeschi C; Valeyrie-Allanore L; Ortonne N; Gressier L; Wallet-Faber N; Bernard PH; Hezode C; Duclos-Vallée JC; Samuel D; Mallet V; Pol S; Milpied B; Dupin N
    J Eur Acad Dermatol Venereol; 2016 Jan; 30(1):143-6. PubMed ID: 25187266
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of adding ribavirin to interferon to treat chronic hepatitis C infection: a systematic review and meta-analysis of randomized trials.
    Brok J; Gluud LL; Gluud C
    Arch Intern Med; 2005 Oct; 165(19):2206-12. PubMed ID: 16246984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antiviral therapy of hepatitis C].
    Erhardt A; Petry W; Ebel M; Jablonowski H; Heintges T; Häussinger D
    Z Gastroenterol; 2000 Mar; 38(3):259-69. PubMed ID: 10768250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Severe bone marrow aplasia due to triple therapy for hepatitis C virus infection: Apropos of a case].
    Bautista Galán C; Serrato AR; Albandea Moreno C; Ruiz Arredondo J
    Gastroenterol Hepatol; 2015 Nov; 38(9):542-3. PubMed ID: 25835261
    [No Abstract]   [Full Text] [Related]  

  • 34. Diagnosis and management of chronic hepatitis C.
    Sharara AI
    J Med Liban; 1999; 47(6):339-42. PubMed ID: 10758707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strategies for managing anemia in hepatitis C patients undergoing antiviral therapy.
    McHutchison JG; Manns MP; Brown RS; Reddy KR; Shiffman ML; Wong JB
    Am J Gastroenterol; 2007 Apr; 102(4):880-9. PubMed ID: 17397412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Peripheral facial paralysis during interferon treatment in hepatitis C: recovery without antiviral therapy withdrawal].
    de Artaza T; Sánchez JJ; González C; Pérez-Grueso MJ; Repiso A; Gómez R; Potenciano JL
    Gastroenterol Hepatol; 2004; 27(7):434-5. PubMed ID: 15461949
    [No Abstract]   [Full Text] [Related]  

  • 37. The burden of HCV treatment in patients with inherited bleeding disorders.
    Fransen van de Putte DE; Fischer K; Posthouwer D; Mauser-Bunschoten EP
    Haemophilia; 2011 Sep; 17(5):791-9. PubMed ID: 21689211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Depression in chronic hepatitis: the virus, the drug, or the ethnic background?
    Ferenci P; Staufer K
    Liver Int; 2008 Apr; 28(4):429-31. PubMed ID: 18339069
    [No Abstract]   [Full Text] [Related]  

  • 39. Overview of interferon therapy for chronic hepatitis C.
    Ahmed A; Keeffe EB
    Clin Liver Dis; 1999 Nov; 3(4):757-73. PubMed ID: 11291249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of hepatitis C with interferon and ribavirin.
    Pianko S; McHutchison JG
    J Gastroenterol Hepatol; 2000 Jun; 15(6):581-6. PubMed ID: 10921409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.